OR WAIT null SECS
August 06, 2018
Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.
August 02, 2018
Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies.
July 27, 2018
The National Science Foundation grant will be used to commercialize a synthetic biology platform for cancer drug development.
July 06, 2018
Sanofi will open a R&D operations hub in Chengdu, Sichuan province, China, with a focus on digitalization and big data analysis.
June 06, 2018
Under the contract, AMRI will focus on the development and manufacture of APIs and drug product for Phase I clinical studies.
April 24, 2018
Scientists at Washington University School of Medicine in St. Louis have developed a new method that could help increase the long-term effectiveness of gene therapy.
Research from Gladstone Institutes suggests that transplanting genetically altered interneurons could improve cognitive function for Alzheimer’s disease.
April 20, 2018
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
The contract renewal allows AMRI to continue to provide medicinal chemistry and ADME services for advancing drug discovery programs in neurotherapeutics.
April 13, 2018
Pharmaceutical Technology will host a panel discussion focused on early drug development on April 24, 2018 at CPhI North America.